Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evolus Lowers FY2025 Sales Guidance from $345.000M-$355.000M to $295.000M-$305.000M vs $348.308M Est

Author: Benzinga Newsdesk | August 05, 2025 03:19pm
Evolus (NASDAQ:EOLS) lowers FY2025 sales outlook from $345.000 million-$355.000 million to $295.000 million-$305.000 million vs $348.308 million estimate.

Posted In: EOLS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist